China Resources Double-Crane Pharmaceutical (600062.SS) Earnings Analysis
China Resources Double-Crane Pharmaceutical (600062.SS) has no confirmed upcoming earnings date. Trailing P/E 10.90.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 600062.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 600062.SS. This page updates as the calendar is published.
600062.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-24 | 0.47 CNY | n/a | n/a | n/a |
| 2026-03-19 | 0.29 CNY | n/a | n/a | n/a |
| 2025-10-24 | 0.3601 CNY | n/a | n/a | n/a |
| 2025-04-26 | 0.4877 CNY | n/a | n/a | n/a |
| 2025-03-19 | 0.2244 CNY | n/a | n/a | n/a |
| 2024-10-25 | 0.3404 CNY | n/a | n/a | n/a |
| 2024-08-22 | 0.614 CNY | n/a | n/a | n/a |
600062.SS valuation and analyst view
| Trailing P/E | 10.90 |
|---|---|
| Trailing EPS | 1.565 CNY |
| Price / book | 1.47 |
| Dividend yield | 2.75% |
| Market cap | 17.82B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is China Resources Double-Crane Pharmaceutical (600062.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 600062.SS. This page updates as the calendar is published.
Did 600062.SS beat earnings last quarter?
Consensus estimate data was not available for 600062.SS's 2026-04-24 report.
What is 600062.SS's current P/E ratio and EPS?
600062.SS trades at a trailing P/E of 10.90 on trailing EPS of 1.5645047269641446 CNY.
What do analysts rate 600062.SS?
600062.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.